Skip to main content

Advertisement

Log in

Spatially resolved metabolomic characterization of muscle invasive bladder cancer by mass spectrometry imaging

  • Original Article
  • Published:
Metabolomics Aims and scope Submit manuscript

Abstract

Introduction

Muscle invasive bladder cancer (MIBC) is an advanced stage of bladder cancer which poses a severe threat to life. Cancer development is usually accompanied by remarkable alterations in cell metabolism, and hence deep insights into MIBC at the metabolomic level can facilitate the understanding of the biochemical mechanisms involved in the cancer development and progression.

Methods

In this proof-of-concept study, the optimal cutting temperature (OCT)-embedded MIBC samples were first washed with pure water to remove the polymer compounds which could cause severe signal suppression during mass spectrometry. Further, the tissue sections were analyzed by infrared matrix-assisted laser desorption electrospray ionization mass spectrometry imaging (IR-MALDESI MSI), providing an overview on the spatially resolved metabolomic profiles.

Results

The MSI data enabled the discrimination between not only the cancerous and normal tissues, but also the subregions within a tissue section associated with different disease states. Using t-Distributed Stochastic Neighbor Embedding (t-SNE), the hyperdimensional MSI data was mapped into a two-dimensional space to visualize the spectral similarity, providing evidence that metabolomic alterations might have occurred outside the histopathological tumor border. Least absolute shrinkage and selection operator (LASSO) was further employed to classify sample pathology in a pixel-wise manner, yielding excellent prediction sensitivity and specificity up to 96% based on the statistically characteristic spectral features.

Conclusion

The results demonstrate great promise of IR-MALDESI MSI to identify molecular changes derived from cancer and unveil tumor heterogeneity, which can potentially promote the discovery of clinically relevant biomarkers and allow for applications in precision medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The data sets are available at https://metaspace2020.eu/project/tu-2021.

Abbreviations

PC:

Phosphatidylcholine

PE:

Phosphatidylethanolamine

PI:

Phosphatidylinositol

PS:

Phosphatidylserine

PG:

Phosphatidylglycerol

FA:

Fatty acid

MG:

Monoglyceride

DG:

Diglyceride

TG:

Triglyceride

CE:

Cholesteryl ester

References

Download references

Acknowledgements

We acknowledge the funding support from National Institutes of Health (NIH) Grants R01-CA193437R01 (to NS), the Wake Forest Baptist Comprehensive Cancer Center Tumor Tissue and Pathology Shared Resource (TTPSR), supported by the National Cancer Institute’s Cancer Center Support Grant Award Number P30CA012197, and the NIH Grant R01GM087964 (to DCM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute. The MSI analysis was performed in the Molecular Education, Technology and Research Innovation Center (METRIC) at NC State University.

Author information

Authors and Affiliations

Authors

Contributions

AT, NS and DCM designed the experiment. AT collected and analyzed the mass spectrometry imaging data. NS provided the human samples and conducted histopathological evaluation. NS and DCM assisted in interpretation of the results. AT, NS and DCM wrote the manuscript. All authors read and approved the manuscript.

Corresponding author

Correspondence to David C. Muddiman.

Ethics declarations

Conflict of interest

The authors declare no competing financial interests.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tu, A., Said, N. & Muddiman, D.C. Spatially resolved metabolomic characterization of muscle invasive bladder cancer by mass spectrometry imaging. Metabolomics 17, 70 (2021). https://doi.org/10.1007/s11306-021-01819-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11306-021-01819-x

Keywords

Navigation